Drug
Ro6870810
Ro6870810: highest development phase Phase 1, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| RO6870810 NCT01987362 | Phase 1 | Solid Tumors, Advanced Solid Tumors |
Latest
No recent events.
Follow Ro6870810 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.